Due to inclement weather, our offices will close at 12pm on Wednesday (2/19), remain closed on Thursday and Friday, and will reopen on Monday (2/24). For more information, please call our inclement weather lines at 757-264-4994 on the Peninsula and 757-264-4990 on the Southside and in Elizabeth City.
2025 UPDATES: Please bring all new insurance cards to your next appointment and verify your address and phone number when you check in at the front desk. 

Virginia Oncology Associates

Virginia Oncology Associates

Clinical Research & Trials

Cancer Center » Clinical Research & Trials » Available Trials » USO 21546

USO 21546

TiNivo-2: A Phase 3, Randomized, Controlled, Multicenter, Open-label Study to Compare Tivozanib in Combination with Nivolumab to Tivozanib Monotherapy in Subjects with Renal Cell Carcinoma Who Have Progressed Following One or Two Lines of Therapy Where One Line has an Immune Checkpoint Inhibitor (AV-951-20-304)

 

Disease Types: Genitourinary Cancer Research

Available at:

Virginia Oncology Associates